309 related articles for article (PubMed ID: 37033630)
1. Therapeutic potential of TRPM8 channels in cancer treatment.
Ochoa SV; Casas Z; Albarracín SL; Sutachan JJ; Torres YP
Front Pharmacol; 2023; 14():1098448. PubMed ID: 37033630
[TBL] [Abstract][Full Text] [Related]
2. Transient Receptor Potential Melastatin 8 (TRPM8) Channel Regulates Proliferation and Migration of Breast Cancer Cells by Activating the AMPK-ULK1 Pathway to Enhance Basal Autophagy.
Huang Y; Li S; Jia Z; Zhao W; Zhou C; Zhang R; Ali DW; Michalak M; Chen XZ; Tang J
Front Oncol; 2020; 10():573127. PubMed ID: 33344232
[TBL] [Abstract][Full Text] [Related]
3. TRPM8 Ion Channels as Potential Cancer Biomarker and Target in Pancreatic Cancer.
Yee NS
Adv Protein Chem Struct Biol; 2016; 104():127-155. PubMed ID: 27038374
[TBL] [Abstract][Full Text] [Related]
4. TRPM8 and prostate: a cold case?
Noyer L; Grolez GP; Prevarskaya N; Gkika D; Lemonnier L
Pflugers Arch; 2018 Oct; 470(10):1419-1429. PubMed ID: 29926226
[TBL] [Abstract][Full Text] [Related]
5. [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters].
Ouadid-Ahidouch H; Dhennin-Duthille I; Gautier M; Sevestre H; Ahidouch A
Bull Cancer; 2012 Jun; 99(6):655-64. PubMed ID: 22640890
[TBL] [Abstract][Full Text] [Related]
6. TRPM8 Puts the Chill on Prostate Cancer.
Grolez GP; Gkika D
Pharmaceuticals (Basel); 2016 Jul; 9(3):. PubMed ID: 27409624
[TBL] [Abstract][Full Text] [Related]
7. TRPM8: a potential target for cancer treatment.
Liu Z; Wu H; Wei Z; Wang X; Shen P; Wang S; Wang A; Chen W; Lu Y
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1871-81. PubMed ID: 26803314
[TBL] [Abstract][Full Text] [Related]
8. The emerging pharmacology of TRPM8 channels: hidden therapeutic potential underneath a cold surface.
Mälkiä A; Morenilla-Palao C; Viana F
Curr Pharm Biotechnol; 2011 Jan; 12(1):54-67. PubMed ID: 20932258
[TBL] [Abstract][Full Text] [Related]
9. Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion.
Yee NS
Cancers (Basel); 2015 Oct; 7(4):2134-46. PubMed ID: 26512697
[TBL] [Abstract][Full Text] [Related]
10. TRPM8 is required for survival and radioresistance of glioblastoma cells.
Klumpp D; Frank SC; Klumpp L; Sezgin EC; Eckert M; Edalat L; Bastmeyer M; Zips D; Ruth P; Huber SM
Oncotarget; 2017 Nov; 8(56):95896-95913. PubMed ID: 29221175
[TBL] [Abstract][Full Text] [Related]
11. Global Trends and Hotspots of Transient Receptor Potential Melastatin 8 Research from 2002 to 2021: A Bibliometric Analysis.
Zhang Z; Kang L; Yan X; Leng Z; Fang K; Chen T; Xu M
J Pain Res; 2022; 15():3881-3892. PubMed ID: 36536695
[TBL] [Abstract][Full Text] [Related]
12. N-glycosylation of the transient receptor potential melastatin 8 channel is altered in pancreatic cancer cells.
Ulăreanu R; Chiriţoiu G; Cojocaru F; Deftu A; Ristoiu V; Stănică L; Mihăilescu DF; Cucu D
Tumour Biol; 2017 Aug; 39(8):1010428317720940. PubMed ID: 28857015
[TBL] [Abstract][Full Text] [Related]
13. The TRPM8 channel as a potential therapeutic target for bladder hypersensitive disorders.
Aizawa N; Fujita T
J Smooth Muscle Res; 2022; 58(0):11-21. PubMed ID: 35354708
[TBL] [Abstract][Full Text] [Related]
14. Transient Receptor Potential Melastatin 8, a sensor of cold temperatures mediates expression of cyclin-dependent kinase inhibitor, p21/Cip1, a regulator of epidermal cell proliferation.
Fujino T
J Toxicol Sci; 2022; 47(3):117-123. PubMed ID: 35236803
[TBL] [Abstract][Full Text] [Related]
15. Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.
Wang Y; Wang X; Yang Z; Zhu G; Chen D; Meng Z
Pathol Oncol Res; 2012 Oct; 18(4):903-10. PubMed ID: 22437241
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels.
Yapa KTDS; Deuis J; Peters AA; Kenny PA; Roberts-Thomson SJ; Vetter I; Monteith GR
Life Sci; 2018 Apr; 198():128-135. PubMed ID: 29496495
[TBL] [Abstract][Full Text] [Related]
17. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.
Bidaux G; Flourakis M; Thebault S; Zholos A; Beck B; Gkika D; Roudbaraki M; Bonnal JL; Mauroy B; Shuba Y; Skryma R; Prevarskaya N
J Clin Invest; 2007 Jun; 117(6):1647-57. PubMed ID: 17510704
[TBL] [Abstract][Full Text] [Related]
18. PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Gkika D; Flourakis M; Lemonnier L; Prevarskaya N
Oncogene; 2010 Aug; 29(32):4611-6. PubMed ID: 20531306
[TBL] [Abstract][Full Text] [Related]
19. TRPM8 channels: A review of distribution and clinical role.
Liu Y; Mikrani R; He Y; Faran Ashraf Baig MM; Abbas M; Naveed M; Tang M; Zhang Q; Li C; Zhou X
Eur J Pharmacol; 2020 Sep; 882():173312. PubMed ID: 32610057
[TBL] [Abstract][Full Text] [Related]
20. Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells.
Thebault S; Lemonnier L; Bidaux G; Flourakis M; Bavencoffe A; Gordienko D; Roudbaraki M; Delcourt P; Panchin Y; Shuba Y; Skryma R; Prevarskaya N
J Biol Chem; 2005 Nov; 280(47):39423-35. PubMed ID: 16174775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
